Skip to content

New oral vaccine is launched for prevention of two canine respiratory pathogens

Merck Animal Well being has introduced the home launch of the primary oral Bordetella bronchiseptica and canine parainfluenza virus vaccine with mucosal safety and straightforward oral administration. The Nobivac Intra-Trac Oral BbPi is predicted to develop into out there for veterinary clinics to buy in the USA in fall 2022, the corporate formulation famous in an organizational launch.1

The vaccine has been proven to be efficient for vaccination of wholesome canines aged 7 weeks or older in opposition to canine parainfluenza virus and Bordetella bronchiseptica. The product is thimerosal-free and accommodates no preservatives, and it affords veterinarians and help employees the flexibility to supply shoppers twin safety in opposition to 2 main respiratory pathogens whereas offering a greater vaccination expertise for canines, in keeping with Merck Animal Well being.

Moreover, the novel know-how of the Immuno-Mist-R applicator by Intervet, a Merck & Co. subsidiary, was instrumental in reaching an efficient oral parainfluenza vaccine. This distinctive applicator offers intensive spray protection extra effectively and delivers broad safety for canines whereas enhancing ease of use for veterinarians and veterinary technicians, in addition to consolation for canine sufferers, in keeping with the corporate.

“For canines in social environments, together with parks, boarding kennels and daycares, coinfection of the respiratory tract with 2 or extra pathogens is usually noticed,” mentioned Madeleine Stahl, DVM, affiliate director medical affairs, Merck Animal Well being, in an organizational information launch . “Given the function that Bordetella and parainfluenza play within the canine infectious respiratory illness complicated, stopping the unfold of each is crucial to guard the respiratory well being of social canines and reduce the potential of future outbreaks—and Nobivac Intra-Trac Oral BbPi does simply that .”

Canine parainfluenza spreads quickly amongst vulnerable canines that work together with each other often or are housed in shut confinement and is among the many commonest causes of extremely contagious acute-onset cough in canines all through the world.two As a result of the virus is excreted from the respiratory tract of contaminated canines for as much as 10 days after an infection and is transmitted by means of the air, it could actually rapidly develop into troublesome to regulate.23

“We’re assured that each veterinary professionals and the canines of their care will profit from the comfort and luxury that Nobivac Intra-Trac Oral BbPi provides, in opposition to 2 essential respiratory pathogens in canines,” mentioned Laura Greene, DVM, DACVIM sr. skilled providers veterinarian – inside drugs at Merck Animal Well being, within the launch.

The vaccine can be out there for veterinary professionals to manage in trays of 25 x 1 dose desiccated vaccine vials and 25 x 1 dose (1 mL) sterile diluent vials. The product is run by gently misting the vaccine orally in the direction of the again of the mouth. Luer lock syringes demarcated with inexperienced plungers and labeled to be used with the twin vaccine in addition to applicator suggestions can be supplied with the acquisition of every vaccine tray to allow correct administration.


  1. Merck Animal Well being Launches Nobivac® Intra-Trac® Oral BbPi for Twin Prevention of Two Main Canine Respiratory Pathogens. Merck Animal Well being. September 12, 2022. Accessed September 13, 2022.
  2. Ford R. Canine infectious respiratory illness. In: Greene CE, ed. Infectious Illnesses of the Canine and Cat. 4th ed.. St. Louis, MO: Saunders/Elsevier;2012:55-65.
  3. Buonavoglia C, Martella V. Canine respiratory viruses. Vet Res. 2007;38:355–373.


Leave a Reply

Your email address will not be published.